Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity (Details 3)

v3.7.0.1
Shareholders' Equity (Details 3) - Stock Options [Member] - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2017
Dec. 31, 2016
Class of Stock [Line Items]    
Number of Shares Underlying Options, Outstanding, Beginning 12,250 12,250
Number of Shares Underlying Options, Granted  
Number of Shares Underlying Options, Exercised  
Number of Shares Underlying Options, Expired  
Number of Shares Underlying Options, Outstanding, Ending 12,250 12,250
Number of Shares Underlying Options, Outstanding and Exercisable 2,722  
Weighted Average Exercise Price Outstanding, Beginning balance $ 19.35  
Weighted Average Exercise Price, Granted  
Weighted Average Exercise Price, Exercised  
Weighted Average Exercise Price, Expired  
Weighted Average Exercise Price Outstanding, Ending balance 19.35 $ 19.35
Weighted Average Exercise Price, Outstanding and Exercisable 19.35  
Weighted Average Grant Date Fair Value Outstanding, Beginning balance 4.78  
Weighted Average Grant Date Fair Value, Granted  
Weighted Average Grant Date Fair Value, Exercised  
Weighted Average Grant Date Fair Value, Expired  
Weighted Average Grant Date Fair Value Outstanding, Ending balance 4.78 $ 4.78
Weighted Average Grant Date Fair Value, Outstanding and Exercisable $ 4.78  
Weighted Average Remaining Contractual Life, Outstanding 4 years 4 months 6 days 4 years 10 months 3 days
Weighted Average Remaining Contractual Life, Outstanding and Exercisable 4 years 4 months 6 days  
Aggregate Intrinsic Value, Outstanding [1]
Aggregate Intrinsic Value, Outstanding and Exercisable [1]  
[1] The aggregate intrinsic value is based on the $1.65 closing price as of June 30, 2017 for the Company's Common Stock.